News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 From our good friends at the End Brain Cancer Initiative, Should be interesting.


Posted on: 05/09/2019


The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner as Advocacy is Underway Now to Bring this Treatment Option to the Seattle Area
Stephanie Lipscomb, the first human to receive modified poliovirus treatment for recurrent GBM (brain cancer) and who was cured. Dr. Annick Desjardins, Stephanie's neuro-oncologist and DUKE researcher. Dr. Desjardins will be keynoting the "Brains Matter" dinner on May 16th. SEATTLE, May 9, 2019 /PRNewswire/ -- The EndBrainCancer Initiative (EBCI) announced today that noted Duke researcher and neuro-oncologist, Annick Desjardins, M.D., will be the keynote speaker at its 8th annual "Brains Matter"

Read in PR Newswire: https://apple.news/Atuwic4OjSt6wdgt3XqMvPA

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740